DexCom Inc (DXCM)
127.02
-1.17
(-0.91%)
USD |
NASDAQ |
May 10, 16:00
127.02
0.00 (0.00%)
After-Hours: 20:00
DexCom Total Assets (Quarterly): 6.482B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 6.482B |
December 31, 2023 | 6.264B |
September 30, 2023 | 6.596B |
June 30, 2023 | 6.821B |
March 31, 2023 | 5.516B |
December 31, 2022 | 5.392B |
September 30, 2022 | 4.899B |
June 30, 2022 | 5.217B |
March 31, 2022 | 5.057B |
December 31, 2021 | 4.933B |
September 30, 2021 | 4.776B |
June 30, 2021 | 4.504B |
March 31, 2021 | 4.390B |
December 31, 2020 | 4.290B |
September 30, 2020 | 3.833B |
June 30, 2020 | 3.522B |
March 31, 2020 | 2.448B |
December 31, 2019 | 2.395B |
September 30, 2019 | 2.186B |
June 30, 2019 | 2.066B |
March 31, 2019 | 1.974B |
December 31, 2018 | 1.916B |
September 30, 2018 | 1.114B |
June 30, 2018 | 1.008B |
March 31, 2018 | 896.80M |
Date | Value |
---|---|
December 31, 2017 | 904.10M |
September 30, 2017 | 842.90M |
June 30, 2017 | 795.60M |
March 31, 2017 | 467.20M |
December 31, 2016 | 402.80M |
September 30, 2016 | 361.90M |
June 30, 2016 | 332.80M |
March 31, 2016 | 299.40M |
December 31, 2015 | 292.00M |
September 30, 2015 | 256.70M |
June 30, 2015 | 218.40M |
March 31, 2015 | 189.30M |
December 31, 2014 | 184.60M |
September 30, 2014 | 159.40M |
June 30, 2014 | 139.70M |
March 31, 2014 | 124.90M |
December 31, 2013 | 122.50M |
September 30, 2013 | 110.10M |
June 30, 2013 | 102.30M |
March 31, 2013 | 98.80M |
December 31, 2012 | 106.00M |
September 30, 2012 | 102.80M |
June 30, 2012 | 110.52M |
March 31, 2012 | 117.96M |
December 31, 2011 | 120.50M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.066B
Minimum
Jun 2019
6.821B
Maximum
Jun 2023
4.579B
Average
4.838B
Median
Total Assets (Quarterly) Benchmarks
Abbott Laboratories | 72.47B |
Edwards Lifesciences Corp | 9.736B |
Boston Scientific Corp | 36.67B |
Cardinal Health Inc | 45.88B |
Insulet Corp | 2.588B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 4.235B |
Shareholders Equity (Quarterly) | 2.247B |
Debt to Equity Ratio | 1.084 |
Current Ratio | 2.898 |
Net Debt Paydown Yield | -0.17% |